Vivanza Biosciences Limited (VIVANZA.BO)
INR 3.5
(-3.58%)
INR 3.5
(-3.58%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 51.69 Million INR | -35.36% |
| 2022 | 79.97 Million INR | 45.19% |
| 2021 | 55.08 Million INR | 1440.68% |
| 2020 | 3.57 Million INR | -7.86% |
| 2019 | 3.87 Million INR | -73.82% |
| 2018 | 14.82 Million INR | 12.04% |
| 2017 | 13.23 Million INR | 47.35% |
| 2016 | 8.97 Million INR | 77.87% |
| 2015 | 5.04 Million INR | 5.21% |
| 2014 | 4.79 Million INR | 24.04% |
| 2013 | 3.86 Million INR | 8.41% |
| 2012 | 3.56 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 62.38 Million INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 51.69 Million INR | -35.36% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 52.66 Million INR | 0.0% |
| 2023 Q4 | 51.69 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 79.97 Million INR | 0.0% |
| 2022 FY | 79.97 Million INR | 45.19% |
| 2022 Q3 | - INR | 0.0% |
| 2021 Q4 | 27.71 Million INR | 0.0% |
| 2021 Q2 | 1.75 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 55.08 Million INR | 1440.68% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q2 | 2.38 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 3.57 Million INR | -7.86% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 3.57 Million INR | 0.0% |
| 2019 Q4 | 3.87 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 3.87 Million INR | -73.82% |
| 2019 Q2 | 7.05 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q2 | 13.93 Million INR | 0.0% |
| 2018 Q4 | 14.82 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 FY | 14.82 Million INR | 12.04% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q2 | 41.67 Million INR | 0.0% |
| 2017 FY | 13.23 Million INR | 47.35% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 13.23 Million INR | 0.0% |
| 2016 Q2 | 19.16 Million INR | 0.0% |
| 2016 Q4 | 8.97 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 FY | 8.97 Million INR | 77.87% |
| 2016 Q1 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 5.04 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 5.04 Million INR | 5.21% |
| 2015 Q4 | 5.04 Million INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 4.79 Million INR | 24.04% |
| 2014 Q4 | 4.79 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 4.79 Million INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 FY | 3.86 Million INR | 8.41% |
| 2013 Q2 | 3.66 Million INR | 0.0% |
| 2013 Q4 | 3.86 Million INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2012 FY | 3.56 Million INR | 0.0% |
| 2012 Q4 | 3.56 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.56 Million INR | -102.222% |
| KIMIA BIOSCIENCES LIMITED | 437.07 Million INR | 88.172% |
| SHELTER PHARMA LIMITED | 5.77 Million INR | -795.462% |
| Vasundhara Rasayans Limited | 19.46 Million INR | -165.579% |
| Sunil Healthcare Limited | 661.51 Million INR | 92.185% |
| Chemo Pharma Laboratories Limited | - INR | -Infinity% |
| MedPlus Health Services Limited | 10.09 Billion INR | 99.488% |
| Bharat Immunologicals & Biologicals Corporation Limited | 702.24 Million INR | 92.639% |
| Patidar Buildcon Limited | 25.32 Million INR | -104.142% |
| Roopa Industries Limited | 258.54 Million INR | 80.005% |
| Smruthi Organics Limited | 117.03 Million INR | 55.829% |
| Trident Lifeline Limited | 184.1 Million INR | 71.921% |
| PANJON LTD. | 14.36 Million INR | -259.768% |
| Pharmaids Pharmaceuticals Limited | 85.32 Million INR | 39.416% |
| Gujarat Terce Laboratories Limited | 38.66 Million INR | -33.7% |
| TIAAN CONSUMER LIMITED | 14.8 Million INR | -249.291% |
| Anuh Pharma Limited | 26.92 Million INR | -91.975% |
| Crestchem Limited | - INR | -Infinity% |
| Emmessar Biotech & Nutrition Limited | 1.09 Million INR | -4625.32% |
| Sandu Pharmaceuticals Limited | 633 Thousand INR | -8066.667% |
| Tyche Industries Limited | - INR | -Infinity% |
| Fredun Pharmaceuticals Limited | 1.05 Billion INR | 95.1% |
| Trimurthi Limited | - INR | -Infinity% |
| Shukra Pharmaceuticals Limited | 31.53 Million INR | -63.908% |
| Norris Medicines Limited | 215.23 Million INR | 75.982% |
| Zenlabs Ethica Limited | 148.59 Million INR | 65.211% |
| Vikram Thermo (India) Limited | 70.43 Million INR | 26.608% |
| ANG Lifesciences India Limited | 728.36 Million INR | 92.903% |
| Parmax Pharma Limited | 53.72 Million INR | 3.775% |
| Veerhealth Care Limited | - INR | -Infinity% |
| Deccan Health Care Limited | 18.95 Million INR | -172.782% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 95.069% |
| Makers Laboratories Limited | 194.92 Million INR | 73.479% |
| Lactose (India) Limited | 392.52 Million INR | 86.83% |
| OXYGENTA PHARMACEUTICAL LIMITE | 572.33 Million INR | 90.968% |
| Zenith Healthcare Limited | - INR | -Infinity% |
| Sanjivani Paranteral Limited. | 9.69 Million INR | -433.433% |
| Bacil Pharma Limited | 984 Thousand INR | -5153.557% |
| PRAVEG LIMITED | 596.11 Million INR | 91.328% |
| Denis Chem Lab Limited | 10.46 Million INR | -394.216% |
| Kwality Pharmaceuticals Limited | 981.19 Million INR | 94.731% |
| Jenburkt Pharmaceuticals Limited | - INR | -Infinity% |
| Colinz Laboratories Limited | 5.69 Million INR | -807.248% |
| Godavari Drugs Limited | 556.24 Million INR | 90.707% |
| SHAMROCK INDUSTRIAL CO.LTD. | - INR | -Infinity% |
| Zenotech Laboratories Limited | - INR | -Infinity% |
| Panchsheel Organics Limited | 63.09 Million INR | 18.063% |
| Shree Ganesh Remedies Limited | 364.49 Million INR | 85.817% |
| Phaarmasia Limited | 1.44 Million INR | -3487.439% |
| Sastasundar Ventures Limited | 38.82 Million INR | -33.138% |
| Medi-Caps Limited | - INR | -Infinity% |
| DECIPHER LABS LIMITED | - INR | -Infinity% |
| Gujarat Themis Biosyn Limited | 27.68 Million INR | -86.732% |
| Ambalal Sarabhai Enterprises Limited | 461.12 Million INR | 88.789% |
| Mercury Laboratories Limited | 55.53 Million INR | 6.916% |
| Gennex Laboratories Limited | 57.2 Million INR | 9.632% |
| BDH Industries Limited | 86.9 Million INR | 40.517% |
| Coral Laboratories Limited | - INR | -Infinity% |
| Concord Drugs Limited | 165.94 Million INR | 68.847% |
| Bharat Parenterals Limited | 1.57 Billion INR | 96.719% |
| Beryl Drugs Limited | 50.93 Million INR | -1.484% |
| Vista Pharmaceuticals Limited | 79.64 Million INR | 35.096% |
| Evoq Remedies Limited | 42.38 Million INR | -21.974% |
| Add-Shop E-Retail Limited | 127.73 Million INR | 59.531% |
| Transchem Limited | - INR | -Infinity% |
| Ishita Drugs and Industries Limited | - INR | -Infinity% |
| Parnax Lab Limited | 806.38 Million INR | 93.589% |
| Source Natural Foods and Herbal Supplements Limited | 35 Thousand INR | -147600.0% |
| Kerala Ayurveda Limited | 675.77 Million INR | 92.35% |
| Cian Healthcare Limited | 556.91 Million INR | 90.718% |
| Trinity League India Limited | 242 Thousand INR | -21261.57% |
| Syschem (India) Limited | 4.5 Million INR | -1048.778% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 96.299% |
| Natural Capsules Limited | 1.09 Billion INR | 95.258% |
| Auro Laboratories Limited | 262.43 Million INR | 80.302% |